These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32182706)

  • 1. Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment.
    Del Campo L; Sánchez-López A; González-Gómez C; Andrés-Manzano MJ; Dorado B; Andrés V
    Cells; 2020 Mar; 9(3):. PubMed ID: 32182706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson-Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite.
    Del Campo L; Sánchez-López A; Salaices M; von Kleeck RA; Expósito E; González-Gómez C; Cussó L; Guzmán-Martínez G; Ruiz-Cabello J; Desco M; Assoian RK; Briones AM; Andrés V
    Aging Cell; 2019 Jun; 18(3):e12936. PubMed ID: 30884114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
    Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
    Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
    Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
    Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
    Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome.
    Hamczyk MR; Andrés V
    Nucleus; 2019 Dec; 10(1):28-34. PubMed ID: 30900948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells.
    Benedicto I; Carmona RM; Barettino A; Espinós-Estévez C; Gonzalo P; Nevado RM; de la Fuente-Pérez M; Andrés-Manzano MJ; González-Gómez C; Rolas L; Dorado B; Nourshargh S; Hamczyk MR; Andrés V
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2400752121. PubMed ID: 38648484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Macías Á; Díaz-Larrosa JJ; Blanco Y; Fanjul V; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; da Rocha AM; Ponce-Balbuena D; Allan A; Filgueiras-Rama D; Jalife J; Andrés V
    Cardiovasc Res; 2022 Jan; 118(2):503-516. PubMed ID: 33624748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells.
    Hamczyk MR; Villa-Bellosta R; Quesada V; Gonzalo P; Vidak S; Nevado RM; Andrés-Manzano MJ; Misteli T; López-Otín C; Andrés V
    EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30862662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with
    Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V
    Cells; 2020 Oct; 9(10):. PubMed ID: 33049978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.
    Benedicto I; Dorado B; Andrés V
    Cells; 2021 May; 10(5):. PubMed ID: 34064612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial-to-Mesenchymal Transition Contributes to Accelerated Atherosclerosis in Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; Nevado RM; Gonzalo P; Andrés-Manzano MJ; Nogales P; Quesada V; Rosado A; Torroja C; Sánchez-Cabo F; Dopazo A; Bentzon JF; López-Otín C; Andrés V
    Circulation; 2024 Nov; 150(20):1612-1630. PubMed ID: 39206565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of poly(ADP-Ribosyl)ation reduced vascular smooth muscle cells loss and improves aortic disease in a mouse model of human accelerated aging syndrome.
    Cardoso D; Guilbert S; Guigue P; Carabalona A; Harhouri K; Peccate C; Tournois J; Guesmia Z; Ferreira L; Bartoli C; Levy N; Colleaux L; Nissan X; Muchir A
    Cell Death Dis; 2024 Oct; 15(10):723. PubMed ID: 39353941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
    Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
    J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progeria-based vascular model identifies networks associated with cardiovascular aging and disease.
    Ngubo M; Chen Z; McDonald D; Karimpour R; Shrestha A; Yockell-Lelièvre J; Laurent A; Besong OTO; Tsai EC; Dilworth FJ; Hendzel MJ; Stanford WL
    Aging Cell; 2024 Jul; 23(7):e14150. PubMed ID: 38576084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.
    Kang SM; Seo S; Song EJ; Kweon O; Jo AH; Park S; Woo TG; Kim BH; Oh GT; Park BJ
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin delays premature aging in Hutchinson-Gilford progeria syndrome.
    Ferreira-Marques M; Carvalho A; Franco AC; Leal A; Botelho M; Carmo-Silva S; Águas R; Cortes L; Lucas V; Real AC; López-Otín C; Nissan X; de Almeida LP; Cavadas C; Aveleira CA
    Aging Cell; 2023 Dec; 22(12):e13983. PubMed ID: 37858983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
    Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.